サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1720847

オレンシア・アバタセプトの世界市場レポート 2025年

Orencia Abatacept Drug Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
オレンシア・アバタセプトの世界市場レポート 2025年
出版日: 2025年05月01日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

オレンシア・アバタセプト市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）6.5%で51億米ドルに成長します。予測期間の成長は、治療適応症の拡大、併用療法の採用増加、ヘルスケアへのアクセス向上、有利な償還政策、新規用途を模索する進行中の臨床試験、高度な治療選択肢に対する患者の意識の高まりなどに起因すると考えられます。この期間に予想される主な動向には、製剤の改良、皮下投与法の進歩、モニタリングのためのデジタルヘルスソリューションの統合、治療適応の拡大、臨床試験の進展などがあります。

自己免疫疾患の罹患率の増加は、今後数年間におけるオレンシア（アバタセプト）医薬品市場の拡大を牽引すると予想されます。自己免疫疾患は、免疫系が誤って体内の健康な細胞や組織を攻撃することで発症します。遺伝的素因、環境の影響、ライフスタイルの変化など、いくつかの要因がこれらの疾患の有病率上昇に寄与しています。オレンシア（一般名：アバタセプト）は、T細胞の活性化を選択的に調節し、炎症を抑え、関節障害を予防することにより、自己免疫疾患の患者さんを支援します。これにより、疾患管理をサポートし、生活の質を高め、関節リウマチや関節症性乾癬などの疾患に対する他の免疫抑制治療への依存を軽減します。例えば、2024年11月、ドイツを拠点とする団体Versorgungsatlas.deは、2022年、7,324万1,305人の被保険者のうち、630万4,340人が少なくとも1つの自己免疫疾患と診断されたと報告し、その結果、生の有病率は8.61％となりました。その結果、自己免疫疾患の有病率の増加がオレンシア（アバタセプト）医薬品市場の成長に拍車をかけています。

個別化医療の台頭は、オレンシア（アバタセプト）医薬品市場の拡大にさらに貢献しています。個別化医療とは、個人の遺伝的体質、環境、ライフスタイルに基づいて治療やヘルスケア戦略をカスタマイズし、より正確で効果的な結果を保証するアプローチです。個別化医療の採用が拡大している背景には、ゲノム技術の進歩、分子生物学に対するより深い理解、精密診断ツールの利用可能性の向上、副作用を最小限に抑えつつ患者の転帰を改善する標的治療に対する需要などがあります。オレンシア（アバタセプト）は、T細胞の活性化を特異的に調節する標的免疫療法を提供することで個別化医療をサポートし、医療従事者が疾患の重症度、患者プロファイル、治療に対する個々の反応に基づいて治療計画を調整できるようにします。例えば、米国を代表する組織である個別化医療連合（Personalized Medicine Coalition）は2023年、2022年にFDAが承認した新薬の34％は個別化医療によるものであり、過去8年間の新薬承認の少なくとも25％は個別化医療によるものであったと報告しています。その結果、個別化医療の採用拡大がオレンシア（アバタセプト）の需要を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界オレンシア・アバタセプト PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界のオレンシア・アバタセプト市場：成長率分析
  • 世界のオレンシア・アバタセプト市場の実績：規模と成長, 2019-2024
  • 世界のオレンシア・アバタセプト市場の予測：規模と成長, 2024-2029, 2034F
  • 世界オレンシア・アバタセプト総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界のオレンシア・アバタセプト市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 皮下注射
  • 静脈内注入
  • 世界のオレンシア・アバタセプト市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 関節リウマチ
  • 若年性特発性関節炎
  • 乾癬性関節炎
  • その他の用途
  • 世界のオレンシア・アバタセプト市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他の流通チャネル
  • 世界のオレンシア・アバタセプト市場化学療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 高用量化学療法誘発性口腔粘膜炎
  • 標準用量化学療法誘発性口腔粘膜炎
  • 世界のオレンシア・アバタセプト市場放射線治療の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 頭頸部がんの放射線治療誘発性口腔粘膜炎
  • 全身放射線誘発性口腔粘膜炎
  • 世界のオレンシア・アバタセプト市場造血幹細胞移植の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 自家幹細胞移植誘発性口腔粘膜炎
  • 同種幹細胞移植誘発性口腔粘膜炎

第7章 地域別・国別分析

  • 世界のオレンシア・アバタセプト市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のオレンシア・アバタセプト市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • オレンシア・アバタセプト市場：競合情勢
  • オレンシア・アバタセプト市場：企業プロファイル
    • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 世界の市場競合ベンチマーキングとダッシュボード

第32章 主要な合併と買収

第33章 最近の市場動向

第34章 市場の潜在力が高い国、セグメント、戦略

  • オレンシア・アバタセプト市場2029：新たな機会を提供する国
  • オレンシア・アバタセプト市場2029：新たな機会を提供するセグメント
  • オレンシア・アバタセプト市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第35章 付録

目次
Product Code: r34104

Orencia (abatacept) is a biologic drug prescribed for autoimmune disorders that works by inhibiting the activation of T-cells. As a selective co-stimulation modulator, it helps reduce immune system overactivity, thereby lowering inflammation and protecting joints from damage.

The primary product types in the Orencia (abatacept) drug market include subcutaneous injections and intravenous infusions. A subcutaneous injection involves administering the medication into the tissue just beneath the skin using a needle. This drug is used for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and others. It is distributed through multiple channels, such as hospital pharmacies, retail pharmacies, online pharmacies, and other distribution networks.

The orencia abatacept drug market research report is one of a series of new reports from The Business Research Company that provides orencia abatacept drug market statistics, including the orencia abatacept drug industry's global market size, regional shares, competitors with a orencia abatacept drug market share, detailed orencia abatacept drug market segments, market trends and opportunities, and any further data you may need to thrive in the orencia abatacept drug industry. This orencia abatacept drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The orencia abatacept drug market size has grown strongly in recent years. It will grow from $3.71 billion in 2024 to $3.96 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be attributed to the increasing prevalence of autoimmune diseases, rising awareness of biologic therapies, expanding indications for abatacept, growing healthcare expenditure, supportive regulatory approvals, and enhanced market penetration through strategic collaborations.

The orencia abatacept drug market size is expected to see strong growth in the next few years. It will grow to $5.10 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to expanding therapeutic indications, the rising adoption of combination therapies, increased access to healthcare, favorable reimbursement policies, ongoing clinical trials exploring novel applications, and growing patient awareness of advanced treatment options. Key trends expected during this period include improved formulation, advancements in subcutaneous delivery methods, the integration of digital health solutions for monitoring, expanded therapeutic indications, and progress in clinical trials.

The growing incidence of autoimmune diseases is expected to drive the expansion of the Orencia (abatacept) drug market in the coming years. Autoimmune diseases arise when the immune system mistakenly attacks the body's own healthy cells and tissues. Several factors contribute to the increasing prevalence of these diseases, including genetic predisposition, environmental influences, and lifestyle changes. Orencia (abatacept) helps patients with autoimmune disorders by selectively modulating T-cell activation, reducing inflammation, and preventing joint damage. This supports disease management, enhances quality of life, and reduces reliance on other immunosuppressive treatments for conditions such as rheumatoid arthritis and psoriatic arthritis. For example, in November 2024, Versorgungsatlas.de, a Germany-based organization, reported that in 2022, out of 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a raw prevalence rate of 8.61%. As a result, the increasing prevalence of autoimmune diseases is fueling the growth of the Orencia (abatacept) drug market.

The rise of personalized medicine is further contributing to the expansion of the Orencia (abatacept) drug market. Personalized medicine is an approach that customizes treatment and healthcare strategies based on an individual's genetic makeup, environment, and lifestyle, ensuring more precise and effective outcomes. The growing adoption of personalized medicine is driven by advancements in genomic technologies, a deeper understanding of molecular biology, the increased availability of precision diagnostic tools, and the demand for targeted therapies that enhance patient outcomes while minimizing side effects. Orencia (abatacept) supports personalized medicine by providing targeted immunotherapy that specifically modulates T-cell activation, allowing healthcare providers to tailor treatment plans based on disease severity, patient profiles, and individual responses to therapy. For example, in 2023, the Personalized Medicine Coalition, a US-based representative organization, reported that in 2022, the FDA approved personalized medicines for 34% of new drugs, with at least 25% of new drug approvals in each of the previous eight years attributed to personalized medicine. Consequently, the growing adoption of personalized medicine is driving the demand for Orencia (abatacept).

In January 2023, Lotte Biologics Co. Ltd., a South Korea-based biotechnology company, acquired a biopharmaceutical production facility in New York from Bristol Myers Squibb Company for $160 million. This acquisition is aimed at expanding Lotte Biologics' manufacturing capabilities and strengthening its contract development and manufacturing organization (CDMO) services. Bristol Myers Squibb Company, a US-based pharmaceutical company, specializes in developing biopharmaceutical products, including Orencia (abatacept).

The key player in the orencia abatacept drug market is Bristol-Myers Squibb Company.

North America was the largest region in the orencia abatacept drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in orencia abatacept drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the orencia abatacept drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The orencia abatacept drug consists of sales of monotherapy and combination therapy. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Orencia Abatacept Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on orencia abatacept drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for orencia abatacept drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The orencia abatacept drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Subcutaneous Injection; Intravenous Infusion
  • 2) By Application: Rheumatoid Arthritis; Juvenile Idiopathic Arthritis; Psoriatic Arthritis; Other Applications
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
  • Subsegments:
  • 1) By Chemotherapy: High-Dose Chemotherapy-Induced Oral Mucositis; Standard-Dose Chemotherapy-Induced Oral Mucositis
  • 2) By Radiotherapy: Head And Neck Cancer Radiotherapy-Induced Oral Mucositis; Total Body Irradiation-Induced Oral Mucositis
  • 3) By Hematopoietic Stem Cell Transplantation: Autologous Stem Cell Transplantation-Induced Oral Mucositis; Allogeneic Stem Cell Transplantation-Induced Oral Mucositis
  • Companies Mentioned: Bristol-Myers Squibb Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Orencia Abatacept Drug Market Characteristics

3. Orencia Abatacept Drug Market Trends And Strategies

4. Orencia Abatacept Drug Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Orencia Abatacept Drug Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Orencia Abatacept Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Orencia Abatacept Drug Market Growth Rate Analysis
  • 5.4. Global Orencia Abatacept Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Orencia Abatacept Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Orencia Abatacept Drug Total Addressable Market (TAM)

6. Orencia Abatacept Drug Market Segmentation

  • 6.1. Global Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Subcutaneous Injection
  • Intravenous Infusion
  • 6.2. Global Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rheumatoid Arthritis
  • Juvenile Idiopathic Arthritis
  • Psoriatic Arthritis
  • Other Applications
  • 6.3. Global Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channels
  • 6.4. Global Orencia Abatacept Drug Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Dose Chemotherapy-Induced Oral Mucositis
  • Standard-Dose Chemotherapy-Induced Oral Mucositis
  • 6.5. Global Orencia Abatacept Drug Market, Sub-Segmentation Of Radiotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Head And Neck Cancer Radiotherapy-Induced Oral Mucositis
  • Total Body Irradiation-Induced Oral Mucositis
  • 6.6. Global Orencia Abatacept Drug Market, Sub-Segmentation Of Hematopoietic Stem Cell Transplantation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autologous Stem Cell Transplantation-Induced Oral Mucositis
  • Allogeneic Stem Cell Transplantation-Induced Oral Mucositis

7. Orencia Abatacept Drug Market Regional And Country Analysis

  • 7.1. Global Orencia Abatacept Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Orencia Abatacept Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Orencia Abatacept Drug Market

  • 8.1. Asia-Pacific Orencia Abatacept Drug Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Orencia Abatacept Drug Market

  • 9.1. China Orencia Abatacept Drug Market Overview
  • 9.2. China Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Orencia Abatacept Drug Market

  • 10.1. India Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Orencia Abatacept Drug Market

  • 11.1. Japan Orencia Abatacept Drug Market Overview
  • 11.2. Japan Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Orencia Abatacept Drug Market

  • 12.1. Australia Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Orencia Abatacept Drug Market

  • 13.1. Indonesia Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Orencia Abatacept Drug Market

  • 14.1. South Korea Orencia Abatacept Drug Market Overview
  • 14.2. South Korea Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Orencia Abatacept Drug Market

  • 15.1. Western Europe Orencia Abatacept Drug Market Overview
  • 15.2. Western Europe Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Orencia Abatacept Drug Market

  • 16.1. UK Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Orencia Abatacept Drug Market

  • 17.1. Germany Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Orencia Abatacept Drug Market

  • 18.1. France Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Orencia Abatacept Drug Market

  • 19.1. Italy Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Orencia Abatacept Drug Market

  • 20.1. Spain Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Orencia Abatacept Drug Market

  • 21.1. Eastern Europe Orencia Abatacept Drug Market Overview
  • 21.2. Eastern Europe Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Orencia Abatacept Drug Market

  • 22.1. Russia Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Orencia Abatacept Drug Market

  • 23.1. North America Orencia Abatacept Drug Market Overview
  • 23.2. North America Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Orencia Abatacept Drug Market

  • 24.1. USA Orencia Abatacept Drug Market Overview
  • 24.2. USA Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Orencia Abatacept Drug Market

  • 25.1. Canada Orencia Abatacept Drug Market Overview
  • 25.2. Canada Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Orencia Abatacept Drug Market

  • 26.1. South America Orencia Abatacept Drug Market Overview
  • 26.2. South America Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Orencia Abatacept Drug Market

  • 27.1. Brazil Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Orencia Abatacept Drug Market

  • 28.1. Middle East Orencia Abatacept Drug Market Overview
  • 28.2. Middle East Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Orencia Abatacept Drug Market

  • 29.1. Africa Orencia Abatacept Drug Market Overview
  • 29.2. Africa Orencia Abatacept Drug Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Orencia Abatacept Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Orencia Abatacept Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Orencia Abatacept Drug Market Competitive Landscape And Company Profiles

  • 30.1. Orencia Abatacept Drug Market Competitive Landscape
  • 30.2. Orencia Abatacept Drug Market Company Profiles
    • 30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Global Orencia Abatacept Drug Market Competitive Benchmarking And Dashboard

32. Key Mergers And Acquisitions In The Orencia Abatacept Drug Market

33. Recent Developments In The Orencia Abatacept Drug Market

34. Orencia Abatacept Drug Market High Potential Countries, Segments and Strategies

  • 34.1 Orencia Abatacept Drug Market In 2029 - Countries Offering Most New Opportunities
  • 34.2 Orencia Abatacept Drug Market In 2029 - Segments Offering Most New Opportunities
  • 34.3 Orencia Abatacept Drug Market In 2029 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer